Cargando…

Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma

High-dose-rate interstitial brachytherapy (HDR-ISBT) has recently come to be considered one of the most effective treatments for oral cancer. On the other hand, it is important to note that radiation therapy has some side effects. Especially, radiation-induced malignancy is probably the most serious...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchimoto, Yuka, Shimamoto, Hiroaki, Takeshita, Ami, Oya, Kaori, Kishino, Mitsunobu, Fukuda, Yasuo, Toyosawa, Satoru, Oda, Michio, Ogawa, Kazuhiko, Kreiborg, Sven, Mallya, Sanjay M., Murakami, Shumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528838/
https://www.ncbi.nlm.nih.gov/pubmed/36199998
http://dx.doi.org/10.5114/jcb.2022.116149
_version_ 1784801374069850112
author Uchimoto, Yuka
Shimamoto, Hiroaki
Takeshita, Ami
Oya, Kaori
Kishino, Mitsunobu
Fukuda, Yasuo
Toyosawa, Satoru
Oda, Michio
Ogawa, Kazuhiko
Kreiborg, Sven
Mallya, Sanjay M.
Murakami, Shumei
author_facet Uchimoto, Yuka
Shimamoto, Hiroaki
Takeshita, Ami
Oya, Kaori
Kishino, Mitsunobu
Fukuda, Yasuo
Toyosawa, Satoru
Oda, Michio
Ogawa, Kazuhiko
Kreiborg, Sven
Mallya, Sanjay M.
Murakami, Shumei
author_sort Uchimoto, Yuka
collection PubMed
description High-dose-rate interstitial brachytherapy (HDR-ISBT) has recently come to be considered one of the most effective treatments for oral cancer. On the other hand, it is important to note that radiation therapy has some side effects. Especially, radiation-induced malignancy is probably the most serious complication affecting long-term survivors. We report a case of a radiation-induced undifferentiated spindle cell sarcoma that developed following HDR-ISBT for tongue squamous cell carcinoma (SCC). A 39-year-old woman with right tongue SCC underwent HDR-ISBT (60 Gy, 10 fractions, 8 days) treatment. Five years and one month later, a tumor had developed at the primary site. Surgery was performed for the tumor, which was histopathologically diagnosed as an undifferentiated spindle cell sarcoma. That was distinct from the squamous cell origin of the primary cancer. According to recently established criteria for radiation-induced malignancy, this case was classified as a radiation-induced sarcoma. A search of the literature revealed no previous report of radiation-induced malignancy following HDR-ISBT for tongue cancer.
format Online
Article
Text
id pubmed-9528838
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-95288382022-10-04 Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma Uchimoto, Yuka Shimamoto, Hiroaki Takeshita, Ami Oya, Kaori Kishino, Mitsunobu Fukuda, Yasuo Toyosawa, Satoru Oda, Michio Ogawa, Kazuhiko Kreiborg, Sven Mallya, Sanjay M. Murakami, Shumei J Contemp Brachytherapy Case Report High-dose-rate interstitial brachytherapy (HDR-ISBT) has recently come to be considered one of the most effective treatments for oral cancer. On the other hand, it is important to note that radiation therapy has some side effects. Especially, radiation-induced malignancy is probably the most serious complication affecting long-term survivors. We report a case of a radiation-induced undifferentiated spindle cell sarcoma that developed following HDR-ISBT for tongue squamous cell carcinoma (SCC). A 39-year-old woman with right tongue SCC underwent HDR-ISBT (60 Gy, 10 fractions, 8 days) treatment. Five years and one month later, a tumor had developed at the primary site. Surgery was performed for the tumor, which was histopathologically diagnosed as an undifferentiated spindle cell sarcoma. That was distinct from the squamous cell origin of the primary cancer. According to recently established criteria for radiation-induced malignancy, this case was classified as a radiation-induced sarcoma. A search of the literature revealed no previous report of radiation-induced malignancy following HDR-ISBT for tongue cancer. Termedia Publishing House 2022-05-11 2022-06 /pmc/articles/PMC9528838/ /pubmed/36199998 http://dx.doi.org/10.5114/jcb.2022.116149 Text en Copyright © 2022 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Case Report
Uchimoto, Yuka
Shimamoto, Hiroaki
Takeshita, Ami
Oya, Kaori
Kishino, Mitsunobu
Fukuda, Yasuo
Toyosawa, Satoru
Oda, Michio
Ogawa, Kazuhiko
Kreiborg, Sven
Mallya, Sanjay M.
Murakami, Shumei
Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma
title Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma
title_full Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma
title_fullStr Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma
title_full_unstemmed Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma
title_short Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma
title_sort radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528838/
https://www.ncbi.nlm.nih.gov/pubmed/36199998
http://dx.doi.org/10.5114/jcb.2022.116149
work_keys_str_mv AT uchimotoyuka radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma
AT shimamotohiroaki radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma
AT takeshitaami radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma
AT oyakaori radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma
AT kishinomitsunobu radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma
AT fukudayasuo radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma
AT toyosawasatoru radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma
AT odamichio radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma
AT ogawakazuhiko radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma
AT kreiborgsven radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma
AT mallyasanjaym radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma
AT murakamishumei radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma